Skip to content

Non-invasive diagnosis of bladder cancer based on methylation of exfoliated urine cells

Non-invasive diagnosis of bladder cancer based on methylation of exfoliated urine cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098796
Enrollment
Unknown
Registered
2025-03-13
Start date
2024-02-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

Index test:Methylation levels of urine exfoliated cells

Sponsors

Army Medical Center of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Healthy Volunteer Group: 1. Age> 18 years old, male or female. 2. Agree to sign the "Informed Consent Form for Scientific Research". 3. No urinary system diseases. Patient group: 1. Age> 18 years old, male or female. 2. Since the beginning of the study, patients who have come to our department for treatment and have been newly diagnosed as bladder cancer, kidney cancer, prostate cancer, ureteral cancer, renal pelvic cancer, ureteritis, urothelial hyperplasia, and bladder lesions. 3. Agree to sign the "Informed Consent Form for Scientific Research"

Exclusion criteria

Exclusion criteria: 1. Refuse to sign the "Informed Consent for Scientific Research". 2. Those who have recently undergone chemotherapy, immunotherapy and surgery. 3. Those who are unable to obtain enough urine.

Design outcomes

Primary

MeasureTime frame
methylation;

Countries

China

Contacts

Public ContactJun Jiang

Army Medical Center of PLA

jiangjun_64@163.com+86 135 0833 1099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026